Sulham KA - Search Results

1

Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.

Deck DH, Jordan JM, Holland TL, Fan W, Wikler MA, Sulham KA, Ralph Corey G. Deck DH, et al. Among authors: sulham ka. Infect Dis Ther. 2016 Sep;5(3):363-5. doi: 10.1007/s40121-016-0127-9. Infect Dis Ther. 2016. PMID: 27565805 Free PMC article. No abstract available.

2

Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting.

Deck DH, Jordan JM, Holland TL, Fan W, Wikler MA, Sulham KA, Ralph Corey G. Deck DH, et al. Among authors: sulham ka. Infect Dis Ther. 2016 Sep;5(3):353-61. doi: 10.1007/s40121-016-0119-9. Epub 2016 Jul 1. Infect Dis Ther. 2016. PMID: 27370913 Free PMC article.

3

Economic Impact of Oritavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in the Emergency Department or Observation Setting: Cost Savings Associated with Avoidable Hospitalizations.

Lodise TP, Fan W, Sulham KA. Lodise TP, et al. Among authors: sulham ka. Clin Ther. 2016 Jan 1;38(1):136-48. doi: 10.1016/j.clinthera.2015.11.014. Epub 2015 Dec 18. Clin Ther. 2016. PMID: 26708118

4

Use of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Patients Receiving Intravenous Antibiotics: A US Hospital Budget Impact Analysis.

Jensen IS, Lodise TP, Fan W, Wu C, Cyr PL, Nicolau DP, DuFour S, Sulham KA. Jensen IS, et al. Among authors: sulham ka. Clin Drug Investig. 2016 Feb;36(2):157-68. doi: 10.1007/s40261-015-0365-8. Clin Drug Investig. 2016. PMID: 26692006 Free PMC article.

5

Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment.

Lane S, Johnston K, Sulham KA, Syed I, Pollack CV Jr, Holland T, Nathwani D. Lane S, et al. Among authors: sulham ka. Clin Ther. 2016 Mar;38(3):531-44; quiz 544.e1-9. doi: 10.1016/j.clinthera.2016.01.007. Epub 2016 Feb 10. Clin Ther. 2016. PMID: 26874786

6

A Retrospective Cohort Analysis Shows that Coadministration of Minocycline with Colistin in Critically Ill Patients Is Associated with Reduced Frequency of Acute Renal Failure.

Lodise TP, Fan W, Griffith DC, Dudley MN, Sulham KA. Lodise TP, et al. Among authors: sulham ka. Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01165-17. doi: 10.1128/AAC.01165-17. Print 2018 Jan. Antimicrob Agents Chemother. 2017. PMID: 29038261 Free PMC article.

7

Use of Oritavancin in Moderate-to-Severe ABSSSI Patients Requiring IV Antibiotics: A U.S. Payer Budget Impact Analysis.

Jensen IS, Wu E, Fan W, Lodise TP, Nicolau DP, Dufour S, Cyr PL, Sulham KA. Jensen IS, et al. Among authors: sulham ka. J Manag Care Spec Pharm. 2016 Jun;22(6):752-64. doi: 10.18553/jmcp.2016.22.6.752. J Manag Care Spec Pharm. 2016. PMID: 27231802 Free PMC article.

8

Hospital admission patterns in adult patients with skin and soft tissue infections: Identification of potentially avoidable hospital admissions through a retrospective database analysis.

Lodise TP, Fan W, Sulham KA. Lodise TP, et al. Among authors: sulham ka. Hosp Pract (1995). 2015;43(3):137-43. doi: 10.1080/21548331.2015.1076325. Hosp Pract (1995). 2015. PMID: 26224423

9

Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials.

Lodise TP, Redell M, Armstrong SO, Sulham KA, Corey GR. Lodise TP, et al. Among authors: sulham ka. Open Forum Infect Dis. 2017 Jan 19;4(1):ofw274. doi: 10.1093/ofid/ofw274. eCollection 2017 Winter. Open Forum Infect Dis. 2017. PMID: 28480266 Free PMC article.

10

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis.

Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V. Nathwani D, et al. Antimicrob Resist Infect Control. 2014 Oct 20;3(1):32. doi: 10.1186/2047-2994-3-32. eCollection 2014. Antimicrob Resist Infect Control. 2014. PMID: 25371812 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters